(1) examine whether age, CRP, WBC, LY#, EOS#, BAS#, MONO#, PLT and their derived ratios (NLR, PLR and LMR) measured in the early stages of COVID-19 before any treatment were different between groups of: (a) patients without pneumonia vs. patients with chest X-ray-verified pneumonia and (b) non-hospitalized patients vs. hospitalized pneumonia patients requiring oxygen therapy;. The gene discussed is CRP; the disease is susceptibility to pneumonia measurement.